← FDA Drug Approvals (Drugs@FDA)
TREPROSTINIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2019-09-24
Drug application
- FDA Application #
ANDA209382- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TREPROSTINIL
- Generic name
- Treprostinil
- Active ingredients
- TREPROSTINIL
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing status
- Discontinued
- Sponsor
- PH HEALTH
- First approval
- 2019-09-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown